Scott Michael Habig

Scott Michael Habig appears in our data through filings on Aurinia Pharmaceuticals Inc. shares, published by SEC (Form 4). Over a trading history stretching from 9 November 2022 to 6 August 2024, the count stands at 6 filings.

Both buying and selling appear: 1 purchase worth €25k, against 3 sales worth €261k. The net balance comes to €236k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. 2024 to date brings no purchases and 3 sales.

The latest filing, published on 8 August 2024, reports an open-market sale of €89k in Aurinia Pharmaceuticals Inc. The clock since the last published purchase (14 November 2022) now reads 1,457 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.